JAKIM) halal management division director Tuan Bukhari Md Akhir (left) and Duopharma Biotech Bhd chief executive officer (commercial) Wan Amir-Jeffery Wan Abdul Majid.
KUALA LUMPUR: Duopharma Biotech Bhd
recorded a new milestone when it became the first pharmaceutical company to receive Halal certification for an oncology product.
The pharmaceutical company said the certificate was awarded by the Department of Islamic Development Malaysia (JAKIM).
Duopharma said the product is currently approved as an adjuvant treatment for postmenopausal women with early breast cancer as well as a first-line treatment for postmenopausal women with advanced breast cancer.
It added that the Halal oncology product is supplied to both Government and private healthcare hospitals in Malaysia and has recently been approved for export to Brunei and Singapore.
“We are making continuous efforts to provide consumers and patients with access to much-needed medicines and therapies – assured safe for use and effective, high in quality, hygienic and halal from the start.
“Our state-of-the-art highly potent active pharmaceutical ingredients (HAPI) facility plays a vital role in the fight against many diseases, enabling us to embrace innovation and technology to serve patient needs and expand access to specialised therapies,” group managing director Leonard Ariff Abdul Shatar said in a statement.
